Mechanisms of clinical resistance to selective FGFR2 inhibition by lirafugratinib

Annals of Oncology 2026 Open access

Read full text

Authors: H. Ellis, E.R. Balasooriya, A. Varkaris, B. Hajian, J. Wan, M. Shekhar, I. Gritti, V. Vijay, L. Albertelli, S. Piot, K. Lau, A. Kehlmann

+8 more

N. Chevalier, F.W. Nugent, Y. Zhen, V.S. Silveira, W.R. Sellers, R.B. Corcoran, D. Juric, N. Bardeesy

DOI: 10.1016/j.annonc.2026.01.004

Cited by: 5

References: 36

Fields of Study & Subjects

Fibroblast Growth Factor Research Parathyroid Disorders and Treatments Sympathectomy and Hyperhidrosis Treatments

References 36